Clinical Ophthalmology: Current Status and Future Challenges
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 31
Special Issue Editors
Interests: inflammatory bowel disease; gastric cancer
Interests: cyclophosphamide; ocular surface; 5-fluorouracil; breast cancer; chemotherapy
Special Issue Information
Dear Colleagues,
Ophthalmology is a dynamic and rapidly advancing discipline, with new diagnostic tools, treatment options, and surgical techniques reshaping clinical practices. However, the field still faces significant challenges in managing both common and rare ocular conditions, especially with the integration of emerging technologies and personalized medicine.
We are pleased to invite you to submit fresh perspectives on the status of ophthalmology and the challenges that lie ahead for consideration for our Special Issue of Medicina, entitled "Clinical Ophthalmology: Current Status and Future Challenges”.
This Special Issue will highlight state-of-the-art research, clinical innovations, and emerging challenges in ophthalmology, showcasing current advancements and exploring future directions in this field. For this Special Issue, we welcome contributions across the following areas:
- Innovations in Ocular Diagnostics and Imaging: Artificial intelligence applications, biomarker identification, and advanced imaging techniques.
- Therapeutic Advances: Cutting-edge pharmacological treatments and surgical techniques for major ocular diseases such as glaucoma, macular degeneration, diabetic retinopathy, and corneal disorders.
- Minimally Invasive Surgery: Cutting-edge procedures aimed at enhancing patient outcomes.
- Artificial Intelligence and Machine Learning: The impact of AI on clinical decision-making, diagnosis, and patient management in ophthalmology.
- Basic Research: Molecular and histological insights into ocular diseases.
- Global Access to Care: Addressing disparities in ophthalmic treatment worldwide.
- Precision Medicine: Personalized approaches tailored to patient profiles.
- Chronic Disease Management: Strategies for long-term ocular diseases care.
We welcome submissions of original research, basic research articles, review articles and clinical studies that provide new insights, offer innovative solutions, or tackle challenges in clinical ophthalmology. This Special Issue will serve as a platform for interdisciplinary dialogue, helping to shape the future of ophthalmology and its integration into broader medical practices.
Submission Deadline: 31st January 2026
We look forward to receiving your manuscripts and working together to develop clinical and basic ophthalmology research.
Dr. Theodora Papamitsou
Guest Editor
Dr. Athanasios Karamitsos
Dr. Sofia Karachrysafi
Guest Editor Assistants
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- clinical ophthalmology
- ophthalmic pharmacology
- biomarkers in eye diseases
- ocular diagnostics
- AI in ophthalmology
- minimally invasive eye surgery
- retinal diseases
- gene therapy in ophthalmology
- surgical innovations in ophthalmology
- regenerative medicine for eye diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
